Dabigatran etexilate is an anticoagulant drug developed and marketed by Boehringer Ingelheim. The parent compound, dabigatran, is a potent thrombin blocker, but it cannot be administered orally. Adding the hydrophobic carbohexoxy group (“etexilate”) to the imine nitrogen created an orally absorbable prodrug.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.